Choroidal neovascularization management in uveitic patients – our experience

Abstract

Abstract Purpose Choroidal neovascularization (CNV) is well documented complication of posteroir uveitis which can lead to severe visual loss. There are varying management options for this condition. We present our experience in managing CNV in uveitic patients. Methods Retrospective study of uveitic patients with CNV treated in our hospital during last eight years. Data collected were: gender and age of patient, type of uveitis, CNV localization, visual acuity at the time of diagnosis, visual acuity at the last follow‐up visit, management of condition. Results 38 patients with posterior uveitis developed CNV in one or both eyes (12 males, 26 females). Average age at the time of diagnosis was 41,7 years. Management of CNV depended on clinical presentation. Treatment options that were used: laser photocoagulation, photodynamic therapy, corticosteroids, vitreoretinal procedure and anti‐VEGF therapy. Different treatment options were combined in some patients. Some patients were only observed. Follow‐up period ranged from one to eight years. Visual acuity improved in 19 eyes and remained stable in 9 eyes. Conclusion The results of varying management options for CNV in uveitic patients are limited. Individual approach in the management decision is necessary because of various clinical presentations. Additional clinical trials are needed to define an optimal approach.